Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04787328
Recruitment Status : Recruiting
First Posted : March 8, 2021
Last Update Posted : July 27, 2021
Sponsor:
Information provided by (Responsible Party):
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2023
Estimated Study Completion Date : March 2025